1. Title of Derivative Security (Instr. 4) |
2. Date Exercisable and Expiration Date (Month/Day/Year) |
3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) |
4. Conversion or Exercise Price of Derivative Security |
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) |
6. Nature of Indirect Beneficial Ownership (Instr. 5) |
Date Exercisable |
Expiration Date |
Title |
Amount or Number of Shares |
Employee Stock Option (Right to Buy)
|
Â
(2)
|
02/21/2027 |
Common Stock
|
1,643
|
$
48.33
|
D
|
Â
|
Employee Stock Option (Right to Buy)
|
Â
(3)
|
02/21/2028 |
Common Stock
|
1,019
|
$
75.18
|
D
|
Â
|
Employee Stock Option (Right to Buy)
|
Â
(4)
|
02/20/2029 |
Common Stock
|
2,198
|
$
74.07
|
D
|
Â
|
* |
If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
** |
Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) |
Includes 416 shares of common stock of Xylem Inc., and 781 restricted stock units scheduled to vest as follows: 198 on February 21, 2020, 169 on February 20, 2020, 77 on February 21, 2021 and 169 on February 20, 2021 and 168 on Feb 20, 2022. Each restricted stock unit represents the right to receive one share of common stock upon vesting |
(2) |
548 options are fully vested and exercisable and 547 are scheduled to vest on February 21, 2020 |
(3) |
340 options are fully vested and exercisable. 340 options are scheduled to vest on February 21, 2020 and 339 options are scheduled to vest on February 21, 2021. |
(4) |
These options will vest in three equal parts on February 20, 2020, February 20, 2021 and February 20, 2022. |